Oncology & Cancer

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a review published online ...

Arthritis & Rheumatism

A protein that controls inflammation

A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's ...

page 10 from 34